Search clinical trials for: adult-female

Total 2 results

Novartis Pharmaceuticals

Completed

A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer

Metastatic Breast Cancer | HER-2 Positive Breast Cancer

Belgium, Netherlands, Australia, Italy, United States
Novartis Pharmaceuticals

Terminated

A Trial of Panobinostat and Trastuzumab for Adult Female Patients With HER2 Positive Metastatic Breast Cancer (MBC) Whose Disease Has Progressed on or After Trastuzumab

Breast Cancer

France, Canada, United Kingdom, Germany, Italy, United States

3

Subscribe